share_log

康寧傑瑞製藥-B：(1)根據首次公開發售後購股權計劃授出購股權；及(2)根據限制性股份獎勵計劃授出獎勵股份

ALPHAMAB-B: (1) GRANT OF SHARE OPTIONS UNDER THE POST-IPO SHARE OPTION SCHEME; AND (2) GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME

Hong Kong Stock Exchange ·  Apr 23 07:44
Summary by Moomoo AI
康寧杰瑞制藥-B（「本公司」）於2024年4月23日宣佈，根據首次公開發售後購股權計劃及限制性股份獎勵計劃，向六名合資格僱員授出購股權及獎勵股份。購股權涉及最多1,180,000股普通股，行使價每股4.350港元，有效期十年，並設有業績目標及歸屬時間表。獎勵股份共130,000股，同樣設有歸屬時間表及業績目標。此舉旨在認可僱員對公司的貢獻，並鼓勵他們對公司未來發展的長期支持。授出的購股權及獎勵股份將由受託人管理，不涉及新股發行。
康寧杰瑞制藥-B（「本公司」）於2024年4月23日宣佈，根據首次公開發售後購股權計劃及限制性股份獎勵計劃，向六名合資格僱員授出購股權及獎勵股份。購股權涉及最多1,180,000股普通股，行使價每股4.350港元，有效期十年，並設有業績目標及歸屬時間表。獎勵股份共130,000股，同樣設有歸屬時間表及業績目標。此舉旨在認可僱員對公司的貢獻，並鼓勵他們對公司未來發展的長期支持。授出的購股權及獎勵股份將由受託人管理，不涉及新股發行。
Corning Jerry Pharmaceuticals-B (the “Company”) announced on April 23, 2024 that it has granted purchase rights and bonus shares to six eligible employees under the Initial Public Offering Share Option Plan and Restricted Share Award Scheme. The share option involves up to 1,180,000 shares of ordinary shares at an exercise price of HK$4.350 per share, valid for ten years and has performance targets and an attribution schedule. The bonus shares total 130,000 shares with an allocation schedule and performance targets. This initiative aims to recognise employees' contributions to the company and encourage their long-term support for the future development of the company. The warrants and bonus shares granted will be managed by the Trustee and will not involve the issuance of new shares.
Corning Jerry Pharmaceuticals-B (the “Company”) announced on April 23, 2024 that it has granted purchase rights and bonus shares to six eligible employees under the Initial Public Offering Share Option Plan and Restricted Share Award Scheme. The share option involves up to 1,180,000 shares of ordinary shares at an exercise price of HK$4.350 per share, valid for ten years and has performance targets and an attribution schedule. The bonus shares total 130,000 shares with an allocation schedule and performance targets. This initiative aims to recognise employees' contributions to the company and encourage their long-term support for the future development of the company. The warrants and bonus shares granted will be managed by the Trustee and will not involve the issuance of new shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more